LISINOPRIL
- Product NDC
- 42708-096
- 11-digit product format
- 427080096
- Labeler code
- 42708
- Product ID
- 42708-096_45b39a1c-a181-f57c-e063-6294a90a8834
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- QPharma, Inc.
- Application
- ANDA076164
- Marketing category
- ANDA
- Marketing start
- 2011-11-01
- Substance
- LISINOPRIL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LISINOPRIL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 197884 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-096-30 | LISINOPRIL | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-096 | LISINOPRIL TABLET [QPHARMA, INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20241127_cfd31165-5902-4c94-8fff-2940faa983c1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42708-096-30 | 42708009630 | 30 TABLET in 1 BOTTLE (42708-096-30) | 30 tablet | 2018-03-21 | 0000-00-00 | Yes | No | Current |